Keywords:
Children; epileptic encephalopathy; genetics; neurodevelopment; next-generation sequencing; quality of life; risk factors
Abstract:
CDKL5 deficiency disorder (CDD), a severe developmental and epileptic encephalopathy, is being diagnosed earlier with improved access to genetic testing, but this may also have unanticipated impacts on parents’ experience receiving the diagnosis. This study explores the lived experience of parents receiving a diagnosis of CDD for their child using mixed methods.